Marketaxess Holdings Inc (MKTX) · Oct 23, 2026 · Acquisition

MarketAxess merger proxy adds lawsuits and valuation details

Proxy supplement — $167/share cash consideration; October 29 stockholder vote

MarketAxess files a merger proxy supplement addressing three lawsuits, 15 stockholder demands and previously undisclosed deal-process and valuation details.

MarketAxess is still operating as an electronic fixed-income trading platform, with growth efforts focused on services, block and portfolio trading, and markets beyond U.S. credit; the pending ICE acquisition now dominates the corporate story. Recent results showed higher total trading activity but limited commission growth, while the merger has already suspended normal guidance and monthly volume disclosures.

This filing does not change the deal economics or announce a new transaction. It supplements the definitive proxy ahead of the October 29 special meeting, largely to neutralize disclosure complaints rather than because the company is reopening negotiations. MarketAxess says three complaints were filed and that it had received 15 stockholder demand letters. 〔0〕

ItemFiling detail
Stockholder lawsuits3 complaints (Litigation and Stockholder Demands related to the Definitive Proxy Statement)
Stockholder demand letters15 (Litigation and Stockholder Demands related to the Definitive Proxy Statement)
ICE’s May 27 proposal$175.00 per share, about a 33.6% premium (Background of the Merger)
Final merger consideration$167.00 per share in cash (Background of the Merger)
Base-case 2026E / 2031E revenue$886M / $1,222M (Base Case Projections)
Base-case 2026E / 2031E EBITDA$440M / $623M (Base Case Projections)
J.P. Morgan DCF implied value$166.51–$230.35 base case; $145.14–$200.06 sensitivity case (Discounted Cash Flow Analysis)
J.P. Morgan estimated feeApproximately $65.5M, including $3M payable upon opinion delivery (Miscellaneous)

The new disclosures make the sale process look more documented, not more competitive. MarketAxess adds that it spoke with roughly six other parties between March and July, but none provided a price indication, while the board chose not to contact other parties because it viewed the risks of outreach as outweighing the benefits. That fills in the process history but does not establish a credible competing bid. 〔1〕

The valuation details support the agreed price in the base case but expose sensitivity to weaker assumptions. The disclosed DCF range places the $167 consideration near the bottom of the base-case range and above the midpoint of the sensitivity range, while the sensitivity case assumes materially slower revenue and EBITDA growth by 2031. The filing also clarifies that management has not updated its forecasts since July 29 and withdrew its standalone guidance after announcing the merger. 〔2〕

The litigation is a process complication, not currently a change to the merger. The company denies wrongdoing and says the supplemental disclosures are intended to moot alleged proxy deficiencies, but the existence of injunction requests and multiple demands adds procedural friction before the stockholder vote.

Bottom line: This is a disclosure cleanup around an already-announced $167-per-share acquisition, not a new bid or revised deal. It modestly clarifies the sale process and valuation while confirming that litigation and the October 29 vote remain the key closing hurdles.

What to watch next

Stockholder vote on merger, October 29

Original filing on SEC EDGAR

More Marketaxess Holdings Inc news

MarketAxess merger proxy adds lawsuits and valuation details | MKTX Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.